Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Parotid Neoplasms × Limonene × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Submandibular Gland Neoplasms 1 Parotid Neoplasms 1 Multiple Pulmonary Nodules 1 Breast Neoplasms 1

Interventions

pembrolizumab 1 gadobutrol 1 Standard of Care 1 Radiotherapy 1 Radiation 1 Proton Therapy 1 Practice Guidelines as Topic 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Limonene 1 Erlotinib Hydrochloride 1 Docetaxel 1 Citric Acid 1 Cisplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04296266 2020-03-05

Human Salivary Gland Disposition of Alda-341 in Patients Undergoing Salivary Gland Surgery

Stanford University

Phase EARLY_PHASE1 Completed

Parotid Neoplasms, Submandibular Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡